Lack of in vivo effect of vanadium on GLUT4 translocation in white adipose tissue of streptozotocin-diabetic rats

被引:11
作者
Cam, MC
Brownsey, RW
Rodrigues, B
McNeill, JH
机构
[1] Univ British Columbia, Fac Pharmaceut Sci, Div Pharmacol & Toxicol, Vancouver, BC V6T 1Z3, Canada
[2] Univ British Columbia, Fac Med, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 2001年 / 50卷 / 06期
基金
英国医学研究理事会;
关键词
D O I
10.1053/meta.2001.23296
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Vanadium treatment, in vivo, corrects the severe hyperglycemia observed in streptozotocin (STZ)-diabetic rats. A number of metabolic effects of vanadium have been demonstrated in vitro and might contribute importantly to normalization of glucose homeostasis. However, many in vitro effects of vanadium occur at concentrations substantially higher than those achieved in vivo. Effects of vanadium on white adipose tissue have been particularly well characterized in vitro. To examine the relationship between in vitro and in vivo actions of vanadium, we examined the effects of vanadium treatment on acute glucose tolerance and adipose tissue GLUT4 control in vivo. In agreement with previous studies, vanadium treatment of STZ-diabetic rats restored normoglycemia with no appreciable restoration of insulin secretion. GLUT4 expression in white adipose tissue was reduced by 22% in STZ-diabetic rats compared with controls. Vanadium treatment did not significantly alter GLUT4 expression in controls, but completely restored normal expression levels in STZ-diabetic rats. In overnight-fasted control animals, GLUT4 translocation to the plasma membrane (PM) was maximally elevated (by 50%) in adipose tissue within 5 to 10 minutes after an intravenous (IV) glucose challenge. No glucose-induced translocation of GLUT4 was detected in diabetic rats, and peak PM GLUT4 content was 40% lower than in controls. Vanadium treatment did not increase peak PM GLUT4 content in either control or diabetic animals in response to a glucose load. Finally, the suppression of whole-body acute glucose tolerance in diabetic animals was only partially normalized by vanadium treatment. We conclude: (1) that concentrations of vanadium effective for maintaining normoglycemia in vivo (typically below 30 mu mol/L) promote normal GLUT4 expression, but do not influence the subcellular localization of GLUT4 in white adipose tissue and (2) that in vivo effects of vanadium may not necessarily reflect the actions observed in vitro at supraphysiologic concentrations. Copyright (C) 2001 by W.B, Saunders Company.
引用
收藏
页码:674 / 680
页数:7
相关论文
共 34 条
[1]  
BODEN G, 1996, AM J PHYSIOL, V270, P251
[2]  
BRUCK R, 1991, HEPATOLOGY, V14, P540
[3]   Partial preservation of pancreatic beta-cells by vanadium: Evidence for long-term amelioration of diabetes [J].
Cam, MC ;
Li, WM ;
McNeill, JH .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1997, 46 (07) :769-778
[4]  
CAMPOS P, 1992, YALE JL HUMAN, V4, P282
[5]   OKADAIC ACID, VANADATE, AND PHENYLARSINE OXIDE STIMULATE 2-DEOXYGLUCOSE TRANSPORT IN INSULIN-RESISTANT HUMAN SKELETAL-MUSCLE [J].
CAREY, JO ;
AZEVEDO, JL ;
MORRIS, PG ;
PORIES, WJ ;
DOHM, GL .
DIABETES, 1995, 44 (06) :682-688
[6]   SELECTIVITY OF THE INSULIN-LIKE ACTIONS OF VANADATE ON GLUCOSE AND PROTEIN-METABOLISM IN SKELETAL-MUSCLE [J].
CLARK, AS ;
FAGAN, JM ;
MITCH, WE .
BIOCHEMICAL JOURNAL, 1985, 232 (01) :273-276
[7]   ORAL VANADYL SULFATE IMPROVES HEPATIC AND PERIPHERAL INSULIN SENSITIVITY IN PATIENTS WITH NON-LNSULIN-DEPENDENT DIABETES-MELLITUS [J].
COHEN, N ;
HALBERSTAM, M ;
SHLIMOVICH, P ;
CHANG, CJ ;
SHAMOON, H ;
ROSSETTI, L .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (06) :2501-2509
[8]  
CUSHMAN SW, 1980, J BIOL CHEM, V255, P4758
[9]  
DUBYAK GR, 1980, J BIOL CHEM, V255, P5306
[10]   VANADATE INCREASES CELL-SURFACE INSULIN BINDING AND IMPROVES INSULIN SENSITIVITY IN BOTH NORMAL AND INSULIN-RESISTANT RAT ADIPOCYTES [J].
ERIKSSON, JW ;
LONNROTH, P ;
SMITH, U .
DIABETOLOGIA, 1992, 35 (06) :510-516